Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
22:33:47 EDT Sun 28 Apr 2024
Enter Symbol
or Name
USA
CA



Q:JAZZ - JAZZ PHARMACEUTICALS PLC - http://jazzpharma.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
JAZZ - Q0.1100.11·110.700.1109.46+2.031.9480.652,14410,325107.00  110.8214  106.73146.70  106.60517:10:04Apr 2415 min RT 2¢

Recent Trades - Last 10 of 10325
Time ETExPriceChangeVolume
17:10:04Q105.05-2.381
16:20:01Q109.462.0311
16:04:38Q108.050.621
16:02:12Q109.462.0328
16:02:10Q109.462.036
16:02:08Q109.462.03470
16:02:03Q109.462.03203
16:01:44Q109.462.0333
16:01:42Q109.462.0368
16:01:38Q109.462.0319

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-04-24 16:05U:JAZZNews ReleaseJazz Pharmaceuticals to Present Data Across Growing Oncology Pipeline and Portfolio at ASCO 2024
2024-04-23 11:18U:JAZZNews ReleaseJazz Pharmaceuticals Employees Wear Purple To Support Epilepsy Awareness and Community
2024-04-17 16:15U:JAZZNews ReleaseJazz Pharmaceuticals to Report 2024 First Quarter Financial Results on May 1, 2024
2024-04-10 07:45U:JAZZNews ReleaseJazz Pharmaceuticals to Showcase Expansive Neuroscience Portfolio at American Academy of Neurology Annual Meeting
2024-04-02 07:30U:JAZZNews ReleaseJazz Pharmaceuticals Completes Zanidatamab Biologics License Application for Previously Treated HER2-Positive Metastatic Biliary Tract Cancer
2024-03-28 10:17U:JAZZNews ReleaseCancer and the Combination Approach
2024-03-20 10:18U:JAZZNews ReleaseJazz Pharmaceuticals Celebrates International Women's Day
2024-03-14 12:03U:JAZZNews ReleaseExploring How Jazz Pharmaceuticals Honored U.S. Black History Month
2024-03-12 16:15U:JAZZNews ReleaseJazz Pharmaceuticals to Host Virtual Zanidatamab R&D Day on Tuesday, March 19, 2024
2024-02-28 16:05U:JAZZNews ReleaseJazz Pharmaceuticals Announces Full Year and Fourth Quarter 2023 Financial Results and Provides 2024 Financial Guidance
2024-02-27 07:45U:JAZZNews ReleaseJazz Pharmaceuticals Appoints Patrick Kennedy to its Board of Directors
2024-02-21 07:45U:JAZZNews ReleaseJazz Pharmaceuticals Appoints Philip Johnson as Chief Financial Officer
2024-02-20 16:15U:JAZZNews ReleaseJazz Pharmaceuticals to Participate in Upcoming March Investor Conferences
2024-02-14 16:15U:JAZZNews ReleaseJazz Pharmaceuticals to Report 2023 Full Year and Fourth Quarter Financial Results on February 28, 2024
2024-02-13 10:17U:JAZZNews ReleaseListen to How "Jazz Remix" Fosters a Positive Employee Experience at Jazz Pharmaceuticals
2024-02-09 09:16U:JAZZNews ReleaseHow This CEO Built a Top 50 Pharma Company Focusing on Culture Day 1
2024-02-07 02:00U:JAZZNews ReleaseJazz Pharmaceuticals Enters Definitive Agreement with Redx Pharma to Acquire Global Rights to KRAS Inhibitor Program
2023-12-21 16:05U:JAZZNews ReleaseJazz Pharmaceuticals Provides Update on Phase 2 Trial of Investigational JZP150 in Adult Patients with Post-Traumatic Stress Disorder
2023-12-20 16:15U:JAZZNews ReleaseJazz Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
2023-12-08 13:20U:JAZZNews ReleaseJazz Pharmaceuticals Presents Updated Phase 2a Data at SABCS 2023 Showcasing Potential of Zanidatamab in HER2+/HR+ Metastatic Breast Cancer